Phase I Study of the Humanized Antiepidermal Growth Factor Receptor Monoclonal Antibody EMD72000 in Patients With Advanced Solid Tumors That Express the Epidermal Growth Factor ReceptorU. Vanhoefer, José Baselga, N. Schleucher et al.|Journal of Clinical Oncology|2003Cited by 259
Dual role of chloroquine in liver ischemia reperfusion injury: reduction of liver damage in early phase, but aggravation in late phaseHaoshu Fang, Olaf Dirsch|Cell Death and Disease|2013Cited by 88
GSK-3<i>β</i>Inhibition Attenuates CLP-Induced Liver Injury by Reducing Inflammation and Hepatic Cell ApoptosisHui Zhang, Olaf Dirsch|Mediators of Inflammation|2014Cited by 49
The epidermal growth factor receptor tyrosine kinase inhibitor gefitinib sensitizes colon cancer cells to irinotecanAda Braun, U. Vanhoefer, Katrin Stark et al.|Anti-Cancer Drugs|2005Cited by 30